Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium

Archives of Gynecology and Obstetrics

Volumn 285, Issue 2, 2012, Pages 473-478

  Park, Hyun ^a   Seok, Jun Min ^a   Yoon, Bo Sung ^a   Seong, Seok Ju ^a   Kim, Ji Young ^a   Shim, Jeong Yun ^a   Park, Chong Taik ^a  

^a CHA University   (South Korea)

Author keywords

Endometrial cancer; Fertility; Maintenance therapy; Progestin

Indexed keywords

FARUTAL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADENOCARCINOMA; ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CURETTAGE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RELEASE; DRUG RESPONSE; EARLY CANCER; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; HYSTEROSCOPY; INFERTILITY THERAPY; INTRAUTERINE CONTRACEPTIVE DEVICE; MAINTENANCE THERAPY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT SELECTION; RELAPSE; TREATMENT DURATION;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, ENDOMETRIOID; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; FERTILITY PRESERVATION; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; MAINTENANCE CHEMOTHERAPY; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TIME FACTORS; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84864472238     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1959-x     Document Type: Article

References (26)

1. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP (1998) ProWle of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91:349-354
2. Crissman JD, Azoury RS, Barnes AE, Schellhas HF (1981) Endo-metrial carcinoma in women 40 years of age or younger. Obstet Gynecol 6:699-704
3. Kim WK, Park ED (1994) Endometrial cancers in young women under the age of 40: a clinicopathologic study. Korean J Obstet Gynecol 37:1829-1838
4. Lee SE, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2005) Contemporary trends of endometrial cancer in Korean women. Korean J Gynecol Oncol 16:215-220
5. Creasman WT, Morrow BN, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endo-metrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035-2041
6. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS (2007) The outcomes of 27, 063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 106:282-288
7. Emons G, Heyl W (2000) Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 126:619-623
8. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95:133-138
9. Jadoul P, Donnez J (2003) Conservative treatment may be beneW-cial for young woman with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil Steril 80:1315-1324
10. Gotlieb WH, Beiner ME, Shalmon B, Korach Y, Segal Y, Zmira N, Koupolovic J, Ben-Baruch G (2003) Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 102:718-725
11. Eftekhar Z, Izadi-Mood N, Yarandi F, Shojaei H, Rezaei Z, Mohagheghi S (2009) EYcacy of megestrol acetate (Megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients. Int J Gynecol Cancer 19:249-252
12. Yahata T, Fujita K, Aoki Y, Tanaka K (2006) Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 21:1070-1075
13. Mountzios G, Pectasides D, Bournakis E, Pectasides E, Bozas G, Dimopoulos MA, Papadimitriou CA (2010) Developments in the systemic treatment of endometrial cancer. Crit Rev Oncol Hema-tol. doi:10.1016/j.critrevonc.2010.07. 013
14. Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT (1996) Long-term follow-up of gonadotro-phin-releasing hormone analog treatment for recurrent endome-trial cancer. Gynecol Oncol 63:47-52
15. Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT (1996) Highdose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 14:357-361
16. Thigpen JT, Brady MF, Alvarez RD, Adelson MD, Homesley HD, Manetta A, Soper JT, Given FT (1999) Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17:1736-1744
17. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW (2000) Immunohistochemical proWle of endometrial adeno-carcinoma: a study of 61 cases and review of the literature. Mod Pathol 13:379-388
18. Yamazawa K, Hirai M, Fujito A, Nishi H, Terauchi F, Ishikura H, Shozu M, Isaka K (2007) Fertility-preserving treatment with progestin, and pathologic criteria to predict response, in young women with endometrial cancer. Hum Reprod 22:1953-1958
19. Signorelli M, Caspani G, Bonazzi C, Chiappa V, Perego P, Mang-ioni C (2009) Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases. BJOG 116:114-118
20. Han AR, Kwon YS, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2009) Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endo-metrial adenocarcinoma or atypical complex hyperplasia. Int J Gynecol Cancer 19:147-151
21. Hahn HS, Yoon SG, Hong JS et al (2009) Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 19:1068-1073
22. Ushijima K, Yahata H, Yoshikawa H et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyproges-terone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798-2803
23. Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I (2005) Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106:693-699
24. Mao Y, Wan X, Chen Y, Lv W, Xie X (2010) Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Fertil Steril 93:283-285
25. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kruman RJ (2002) Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186:651-657
26. Lee SY, Kim MK, Park H, Yoon BS, Seong SJ, Kang JH, Jun HS, Park CT (2010) The eVectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women. J Gynecol Oncol 21:102-105